A recent study led by the University of California, Irvine has unveiled new insights into the relationship between cardiovascular risk factors and brain health among individuals aged 90 and older. Traditionally, conditions such as high blood pressure and diabetes have been known contributors to cognitive decline and brain blood vessel damage in younger populations. However, findings from this research suggest that these risks may not hold the same relevance in the oldest demographic.

Rethinking Traditional Risk Factors

Published in the journal Alzheimer's & Dementia, the study indicates that the interactions among blood pressure, cardiovascular conditions, and brain health are considerably more intricate than previously understood. According to Dr. Ravi Rajmohan, the corresponding author and a clinical instructor of neurology at UC Irvine, this revelation challenges long-standing assumptions regarding the impact of traditional cardiovascular risk factors.

The research team analyzed data from 267 participants in the National Institute on Aging's 90+ Study, one of the most comprehensive studies focusing on the oldest-old population. By applying sophisticated statistical models that accounted for variables such as age, sex, and educational background, they found that conventional risk factors like high blood pressure and diabetes were not significantly associated with certain types of brain damage typically observed in this age group.

Potential Benefits of Medications

Interestingly, the study revealed that the use of blood pressure-lowering medications showed positive associations with brain health outcomes. Specific findings included:

  • Diuretics were linked to a lower likelihood of atherosclerosis, a condition often referred to as "hardening of the arteries."
  • Vasodilators were associated with reduced odds of cerebral amyloid angiopathy, which entails the buildup of amyloid proteins in brain blood vessels.

Dr. Rajmohan commented, "Our findings challenge the idea that traditional vascular risk factors are always harmful to brain health in the 90-plus population." The results suggest that either the treatment for these conditions is effective, or individuals with severe untreated risk factors may not reach the age of 90.

Implications for Future Research

This study emphasizes the necessity for further research to examine whether blood pressure-lowering medications can directly mitigate the risks of brain damage and dementia under particular circumstances. Understanding these dynamics could pave the way for personalized treatment strategies aimed at managing blood pressure while enhancing brain health outcomes.

“Our findings may reflect the effectiveness of treatment for those conditions, or they could be influenced by survival bias, as individuals with untreated or severe risk factors may not live into their 90s.” – Dr. Ravi Rajmohan

Study Methodology

To gain comprehensive insights, the researchers utilized an extensive dataset from the 90+ Study to explore the connections between vascular risk factors and cerebrovascular pathological changes observed during autopsy. The statistical models employed were sophisticated enough to consider multiple confounding factors, leading to more robust interpretations of their findings.

Medication Type Associated Benefit Condition Affected
Diuretics Lower atherosclerosis risk Hardening of arteries
Vasodilators Reduced odds of brain protein buildup Cerebral amyloid angiopathy

Conclusion

The insights garnered from this research may redefine approaches to cardiovascular management in elderly populations, particularly regarding cognitive health. Exploring the nuances of how traditional risk factors operate in the context of aging and how they can be managed through medication remains a critical area of investigation.

Literature Cited

Ravi Rajmohan et al., Vascular risk factors and cerebrovascular pathologic changes on autopsy: The 90+ Study, _Alzheimer's & Dementia_ (2025).

Lifespan.io